Smith Group Asset Management’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40	Closed	-$2K	–	391
2021 Q2	$2K	Hold	40	–	–	﹤0.01%	360
2021 Q1	$1K	Sell	40 -1,100	-96%	-$46.9K	﹤0.01%	326
2020 Q4	$52K	Hold	1,140	–	–	﹤0.01%	217
2020 Q3	$31K	Hold	1,140	–	–	﹤0.01%	224
2020 Q2	$42K	Sell	1,140 -20	-2%	-$746	﹤0.01%	209
2020 Q1	$38K	Hold	1,160	–	–	﹤0.01%	256
2019 Q4	$48K	Hold	1,160	–	–	﹤0.01%	281
2019 Q3	$41K	Buy	1,160 +420	+57%	+$17K	﹤0.01%	292
2019 Q2	$38K	Hold	740	–	–	﹤0.01%	291
2019 Q1	$42K	Sell	740 -2,800	-79%	-$139K	﹤0.01%	310
2018 Q4	$149K	Sell	3,540 -100	-3%	-$5.87K	0.01%	264
2018 Q3	$275K	Buy	+3,640	New	+$262K	0.01%	232